REVIVA PHARMACEUTICALS HOLDINGS, INC.·4

Jun 30, 5:52 PM ET

Narayan Prabhu 4

4 · REVIVA PHARMACEUTICALS HOLDINGS, INC. · Filed Jun 30, 2022

Insider Transaction Report

Form 4
Period: 2022-06-30
Narayan Prabhu
Chief Financial Officer
Transactions
  • Purchase

    Common Stock, par value $0.0001 per share

    2022-06-30$1.21/sh+50,000$60,67050,000 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.08 to $1.37 per share, inclusive. The Reporting Person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4